MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$26,863K
EPS
-$0.25
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
16,022
General and administrative
12,252
Total operating expenses
28,274
Loss from operations
-28,274
Interest income
1,411
Total non-operating income
1,411
Net loss
-26,863
Basic EPS
-0.25
Diluted EPS
-0.25
Basic Average Shares
109,051,215
Diluted Average Shares
109,051,215
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$1,411K Net loss-$26,863K Total non-operatingincome$1,411K Loss from operations-$28,274K Total operatingexpenses$28,274K Research and development$16,022K General andadministrative$12,252K

SELLAS Life Sciences Group, Inc. (SLS)

SELLAS Life Sciences Group, Inc. (SLS)